54868-5464 : Didanosine 250 mg Delayed Release Capsule
| NDC: | 54868-5464 |
| Labeler: | Physicians Total Care, Inc. |
| Product Type: | Human Prescription Drug |
| Drug Name: | Didanosine |
| Dosage Form: | Oral Capsule, Delayed Release Pellets |
| Application #: | ANDA077167 |
| Rev. Date: |
Appearance:
| Markings: | barr;250mg;589 |
| Shapes: |
Capsule |
| Colors: |
 Blue /
 White |
| Size (mm): | 23 |
| Segments: * | 1 |
* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines. | |
The above image is provided by the U.S. National Library of Medicine (NLM) and is not part of the official label.
NDC Package Codes:
- 54868-5464-0: 30 CAPSULE, DELAYED RELEASE PELLETS IN 1 BOTTLE (54868‑5464‑0)
Active Ingredients:
- Didanosine
Dosage Strength:
- 250 mg
Inactive Ingredients:
- Ferrosoferric Oxide
- Croscarmellose Sodium
- D&c Yellow No. 10
- Aluminum Oxide
- Fd&c Blue No. 1
- Fd&c Blue No. 2
- Fd&c Red No. 40
- Gelatin
- Hydroxypropyl Cellulose
- Hypromelloses
- Methacrylic Acid
- Cellulose, Microcrystalline
- Polydextrose
- Polyethylene Glycol
- Propylene Glycol
- Shellac
- Silicon Dioxide
- Sodium Hydroxide
- Talc
- Titanium Dioxide
- Triacetin
- Triethyl Citrate
- D&c Red No. 28
Pharmaceutical Classes:
- Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
- Nucleoside Analog [Chemical/Ingredient]
- Nucleoside Reverse Transcriptase Inhibitors [MoA]
Related Products:
Based on records with the same trade name.- 0378-8886 Didanosine 125 mg Delayed Release Capsule by Mylan Pharmaceuticals Inc.
- 0378-8887 Didanosine 200 mg Delayed Release Capsule by Mylan Pharmaceuticals Inc.
- 0378-8888 Didanosine 250 mg Delayed Release Capsule by Mylan Pharmaceuticals Inc.
- 0378-8889 Didanosine 400 mg Delayed Release Capsule by Mylan Pharmaceuticals Inc.
- 0555-0588 Didanosine 200 mg Delayed Release Capsule by Barr Laboratories Inc.
- 0555-0589 Didanosine 250 mg Delayed Release Capsule by Barr Laboratories Inc.
- 0555-0590 Didanosine 400 mg Delayed Release Capsule by Barr Laboratories Inc.
- 53808-0236 Didanosine 250 mg Delayed Release Capsule by State of Florida Doh Central Pharmacy
- 53808-0353 Didanosine 400 mg Delayed Release Capsule by State of Florida Doh Central Pharmacy
- 62584-046 Didanosine 250 mg Delayed Release Capsule by American Health Packaging
- 62584-048 Didanosine 400 mg Delayed Release Capsule by American Health Packaging
- 65862-092 Ddi 100 mg Chewable Tablet by Aurobindo Pharma Limited
- 65862-093 Ddi 150 mg Chewable Tablet by Aurobindo Pharma Limited
- 65862-094 Ddi 200 mg Chewable Tablet by Aurobindo Pharma Limited
- 65862-109 Didanosine 10 mg/ml Oral Powder, for Solution by Aurobindo Pharma Limited
- 65862-110 Didanosine 10 mg/ml Oral Powder, for Solution by Aurobindo Pharma Limited
- 65862-310 Didanosine 125 mg Delayed Release Capsule by Aurobindo Pharma Limited
- 65862-311 Didanosine 200 mg Delayed Release Capsule by Aurobindo Pharma Limited
- 65862-312 Didanosine 250 mg Delayed Release Capsule by Aurobindo Pharma Limited
- 65862-313 Didanosine 400 mg Delayed Release Capsule by Aurobindo Pharma Limited
- More related products ...
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 54868-5463Next: 54868-5465 >
Related Discussions:
didanosineEC
What are side effects? ## Didanosine may cause tingling, burning or numbness in the hands and feet (peripheral neuropath... 2 replies
What are side effects? ## Didanosine may cause tingling, burning or numbness in the hands and feet (peripheral neuropath... 2 replies
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.
